Internet Based Cognitive Behavior Treatment for Alcohol Use Disorders
NCT ID: NCT02645721
Last Updated: 2020-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
166 participants
INTERVENTIONAL
2016-01-31
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Guided and Unguided Internet Treatment for Problematic Alcohol Use
NCT02384304
Effectiveness and Costs of Internet-based Treatment for Harmful Alcohol Use and Face-to-face Treatment in Addiction Care
NCT02671019
Internet-delivered Therapy for Alcohol Misuse: Factorial Trial of Assessment and Guidance
NCT03984786
Web-based CBT4CBT for Alcohol
NCT01615497
Internet-delivered Therapy for Alcohol Misuse: Investigating Patient Preference for Self-guided or Guided Treatment
NCT04611854
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary hypothesis is that the more extended program with guidance (group 1) is more effective in reducing mean alcohol consumption and number of heavy drinking days compared to the briefer program with no guidance (group 2), as well as compared to a waiting list (group 3). A responder to treatment is defined as a participant drinking less than 9 (women)/ 14(men) glasses per week and no more than 3 (women)/4 (men) glasses per drinking day during that week.
A minimum of 169 participants will be recruited in two phases: first through an online screening and then through a diagnostic telephone assessment, where SCID will be used to diagnose Alcohol Use Disorders and MINI will be used to diagnose other psychiatric diagnoses. The telephone assessment and all guidance will be conducted by licensed psychologists or master students in psychology under supervision by licensed psychologists.
Included participants will be randomized into three groups:
Group 1: All participants in this group will have access to an extended cognitive behavioral treatment program and have access to a guide with basic training in psychotherapy (CBT) who assists and counsels the participant throughout the program.
Group 2: Participants in this group will have access to a briefer cognitive behavior treatment program with no access to a guide.
Group 3: Participants in this group will be placed on a waiting list for 12 weeks. Thereafter, they will be given access to the same extended cognitive behavior treatment program as Group 1; they will also be offered a possibility to choose between three guidance options: Choice 1: guide with intensive support, Choice 2: guide with support only at request, Choice 3: no guide.
Interim analyses will be undertaken in May 2016 by graduate students in Clinical psychology writing their MSc theses.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Extended self-help program with guidance
The program is a comprehensive CBT program lasting 12 weeks, with as many modules. The modules are quite extensive. A guide with basic education in psychotherapy assists and counsels participants online.
Extended self-help program with guidance
See arm description for Experimental
Briefer Self-help program, no guidance
This self-help program also lasts 12 weeks but contains only 9 modules; a pause occurs during the final weeks of the program for self-testing of acquired skills. The modules are quite brief. Participants receive no guidance.
Briefer Self-help program, no guidance
See arm description for Active Comparator
WL: Extended self-help program, choice of guidance intensity
Participants will be put on a waiting list. After 12 weeks on the waiting list, participants will receive access the the extended self-help program used in the experimental arm. However, participants will be offered a choice between three guidance options of varying intensity: proactive guidance, reactive guidance (only at participant request) or no guidance.
WL: Extended self-help program, choice of guidance intensity
See arm description for Waiting list.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Extended self-help program with guidance
See arm description for Experimental
Briefer Self-help program, no guidance
See arm description for Active Comparator
WL: Extended self-help program, choice of guidance intensity
See arm description for Waiting list.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* access to the internet
* consumption of at least 9 (females)/14 (males) glasses of alcohol during the preceding week
* AUDIT ≥ 14 for females, ≥ 16 for men
* have an Alcohol Use Disorder according to the DSM-5 (i.e., at least 2 out of 11 criteria)
Exclusion Criteria
* reading or writing difficulties, if it is to a degree that it will hamper the treatment
* concurrent other psychological treatment with a content resembling treatments in this study
* severe depression defined as a score of more than 30 on the MADRS-S
* suicide-risk defined as more than 4 points on the MADRS-S question 9, or based on the structured interview
* Drug use problems defined as ≥ 8 p on the DUDIT
* somatic or psychiatric disorders that are contraindicated for the treatment or impairs the ability to receive it (for example schizophrenia, bipolar disease, PTSD)
* has during the last 3 weeks begun medication for alcohol problems or other psychiatric disorder
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Göteborg University
OTHER
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne H Berman
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne H Berman, PhD
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska Institutet
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015/2014-31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.